Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

G-CSF induces E-selectin ligand expression on human myeloid cells

Nature Medicine volume 12, pages 1185–1190 (2006)Cite this article

Abstract

Clinical use of G-CSF can result in vascular and inflammatory complications1,2,3,4,5,6,7. To investigate the molecular basis of these effects, we analyzed the adherence of G-CSF–mobilized human peripheral blood leukocytes (ML) to inflamed (TNF-α–stimulated) vascular endothelium. Studies using parallel plate assays under physiologic flow conditions and intravital microscopy in a mouse inflammation model each showed that ML take part in heightened adhesive interactions with endothelium compared to unmobilized (native) blood leukocytes, mediated by markedly increased E-selectin receptor-ligand interactions. Biochemical studies showed that ML express the potent E-selectin ligand HCELL (ref. 8) and another, previously unrecognized ∼65-kDa E-selectin ligand, and possess enhanced levels of transcripts encoding glycosyltransferases (ST3GalIV, FucT-IV and FucT-VII) conferring glycan modifications associated with E-selectin ligand activity. Enzymatic treatments and physiologic binding assays showed that HCELL and the ∼65-kDa E-selectin ligand contribute prominently to the observed G-CSF–induced myeloid cell adhesion to inflamed endothelium. Treatment of normal human bone marrow cells with a pharmacokinetically relevant concentration of G-CSF in vitro9,10 resulted in increased expression of these two molecules, coincident with increased transcripts encoding pertinent glycosyltransferases and heightened E-selectin binding. These findings provide direct evidence for a role of G-CSF in the induction of E-selectin ligands on myeloid cells, thus providing mechanistic insight into the pathobiology of G-CSF complications.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: ML possess enhanced binding to E-selectin relative to NL.
Figure 2: ML express multiple HECA–452-reactive E-selectin glycoprotein ligands.
Figure 3: Characterization of PSGL-1, HCELL and a newly identified ∼65-kDa E-selectin ligand on ML.
Figure 4: In vitro G-CSF treatment of human bone marrow cells upregulates the expression of HCELL, HECA-452–reactive ∼65-kDa glycoprotein, ST3GalIV, FucT-IV and FucT-VII.

Similar content being viewed by others

References

  1. Lindemann, A. & Rumberger, B. Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF). Eur. J. Cancer 29A, 2338–2339 (1993).

    Article  CAS  Google Scholar 

  2. Hill, J.M. et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J. Am. Coll. Cardiol. 46, 1643–1648 (2005).

    Article  CAS  Google Scholar 

  3. Arimura, K. et al. Acute lung injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica 90, ECR10 (2005).

    PubMed  Google Scholar 

  4. Fukumoto, Y. et al. Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia. Br. J. Haematol. 97, 666–668 (1997).

    Article  CAS  Google Scholar 

  5. Dereure, O., Hillaire-Buys, D. & Guilhou, J.J. Neutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: manifestations of a neutrophil recovery syndrome? Br. J. Dermatol. 150, 1228–1230 (2004).

    Article  CAS  Google Scholar 

  6. Stricker, R.B. & Goldberg, B. G-CSF and exacerbation of rheumatoid arthritis. Am. J. Med. 100, 665–666 (1996).

    Article  CAS  Google Scholar 

  7. Adler, B.K. et al. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration. Blood 97, 3313–3314 (2001).

    Article  CAS  Google Scholar 

  8. Dimitroff, C.J., Lee, J.Y., Rafii, S., Fuhlbrigge, R.C. & Sackstein, R. CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J. Cell Biol. 153, 1277–1286 (2001).

    Article  CAS  Google Scholar 

  9. van Der Auwera, P. et al. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25–8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim. Am. J. Hematol. 66, 245–251 (2001).

    Article  CAS  Google Scholar 

  10. Faulkner, L.B. et al. G-CSF serum pharmacokinetics during peripheral blood progenitor cell mobilization: neutrophil count-adjusted dosage might potentially improve mobilization and be more cost-effective. Bone Marrow Transplant. 21, 1091–1095 (1998).

    Article  CAS  Google Scholar 

  11. Elfenbein, G.J. & Sackstein, R. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow. Exp. Hematol. 32, 327–339 (2004).

    Article  CAS  Google Scholar 

  12. Sackstein, R. The lymphocyte homing receptors: gatekeepers of the multistep paradigm. Curr. Opin. Hematol. 12, 444–450 (2005).

    Article  Google Scholar 

  13. Kansas, G.S. Selectins and their ligands: current concepts and controversies. Blood 88, 3259–3287 (1996).

    CAS  PubMed  Google Scholar 

  14. Albert, R.K. Mechanisms of the adult respiratory distress syndrome: selectins. Thorax 50 (suppl. 1), S49–S52 (1995).

    Article  Google Scholar 

  15. Kriegsmann, J. et al. Expression of E-selectin messenger RNA and protein in rheumatoid arthritis. Arthritis Rheum. 38, 750–754 (1995).

    Article  CAS  Google Scholar 

  16. Glass, L.F., Fotopoulos, T. & Messina, J.L. A generalized cutaneous reaction induced by granulocyte colony-stimulating factor. J. Am. Acad. Dermatol. 34, 455–459 (1996).

    Article  CAS  Google Scholar 

  17. Bussolino, F. et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337, 471–473 (1989).

    Article  CAS  Google Scholar 

  18. Fuste, B. et al. Granulocyte colony-stimulating factor increases expression of adhesion receptors on endothelial cells through activation of p38 MAPK. Haematologica 89, 578–585 (2004).

    CAS  PubMed  Google Scholar 

  19. Sipkins, D.A. et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435, 969–973 (2005).

    Article  CAS  Google Scholar 

  20. Smith, M.L., Olson, T.S. & Ley, K. CXCR2- and E-selectin-induced neutrophil arrest during inflammation in vivo. J. Exp. Med. 200, 935–939 (2004).

    Article  CAS  Google Scholar 

  21. Kieffer, J.D. et al. Neutrophils, monocytes, and dendritic cells express the same specialized form of PSGL-1 as do skin-homing memory T cells: cutaneous lymphocyte antigen. Biochem. Biophys. Res. Commun. 285, 577–587 (2001).

    Article  CAS  Google Scholar 

  22. Fuhlbrigge, R.C., King, S.L., Dimitroff, C.J., Kupper, T.S. & Sackstein, R. Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on western blots. J. Immunol. 168, 5645–5651 (2002).

    Article  CAS  Google Scholar 

  23. Zollner, O. et al. L-selectin from human, but not from mouse neutrophils binds directly to E-selectin. J. Cell Biol. 136, 707–716 (1997).

    Article  CAS  Google Scholar 

  24. Ohsaka, A. et al. Granulocyte colony-stimulating factor down-regulates the surface expression of the human leucocyte adhesion molecule-1 on human neutrophils in vitro and in vivo. Br. J. Haematol. 84, 574–580 (1993).

    Article  CAS  Google Scholar 

  25. Wagers, A.J., Waters, C.M., Stoolman, L.M. & Kansas, G.S. Interleukin 12 and interleukin 4 control T cell adhesion to endothelial selectins through opposite effects on alpha1, 3-fucosyltransferase VII gene expression. J. Exp. Med. 188, 2225–2231 (1998).

    Article  CAS  Google Scholar 

  26. Hakansson, L. et al. Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion. Br. J. Haematol. 98, 603–611 (1997).

    Article  CAS  Google Scholar 

  27. Jilma, B. et al. Rapid down modulation of P-selectin glycoprotein ligand-1 (PSGL-1, CD162) by G-CSF in humans. Transfusion 42, 328–333 (2002).

    Article  CAS  Google Scholar 

  28. Xia, L. et al. P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. J. Clin. Invest. 109, 939–950 (2002).

    Article  CAS  Google Scholar 

  29. Cowland, J.B. & Borregaard, N. Isolation of neutrophil precursors from bone marrow for biochemical and transcriptional analysis. J. Immunol. Methods 232, 191–200 (1999).

    Article  CAS  Google Scholar 

  30. Zou, X. et al. PSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E-selectin under flow. Am J. Physiol. Cell Physiol. 289, C415–C424 (2005).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to the staff at the Cell Manipulation Core Facility of Dana Farber Cancer Center for their assistance in procuring G-CSF–mobilized peripheral blood pheresis products and to the staff of the Cell Processing Laboratory of the Bone Marrow Transplantation Unit at the Massachusetts General Hospital for their assistance in procuring the bone marrow material. This work was supported by US National Institutes of Health grants RO1 HL060528 (R.S.), RO1 HL073714 (R.S.), the Team Jobie Leukemia Research Fund (R.S.) and RO1 EB000664 and Wellman Center Advanced Microscopy startup fund (C.P.L.).

Author information

Authors and Affiliations

  1. Department of Dermatology, Brigham & Women's Hospital, 77 Avenue Louis Pasteur, Room 671, Harvard Medical School, Boston, 02115, Massachusetts, USA

    Nilesh M Dagia, Samah Z Gadhoum, Christine A Knoblauch & Robert Sackstein

  2. Harvard Skin Disease Research Center, 77 Avenue Louis Pasteur, Room 671, Harvard Medical School, Boston, 02115, Massachusetts, USA

    Nilesh M Dagia, Samah Z Gadhoum, Christine A Knoblauch & Robert Sackstein

  3. Wellman Center for Photomedicine, Massachusetts General Hospital, 55 Fruit Street, Boston, 02114, Massachusetts, USA

    Joel A Spencer, Parisa Zamiri & Charles P Lin

  4. Department of Medicine, Brigham & Women's Hospital, Dana-Farber Cancer Institute,

    Robert Sackstein

  5. Department of Medical Oncology, Dana-Farber Cancer Institute,

    Robert Sackstein

Authors
  1. Nilesh M Dagia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samah Z Gadhoum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Christine A Knoblauch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joel A Spencer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Parisa Zamiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Charles P Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Robert Sackstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

N.M.D. designed the research, performed experiments, analyzed data and wrote the paper; S.Z.G. performed RT-PCR; C.A.K. provided technical assistance; J.A.S. and P.Z. performed intravital microscopy and analyzed data; C.P.L. oversaw intravital microscopy experiments and partially provided funding for the research; R.S. designed research, analyzed data, wrote the paper, provided funding for the research and supervised all experimentation.

Corresponding author

Correspondence to Robert Sackstein.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

mAbs specific to L-selectin, CD29 or CD18 have no effect on primary tethering of ML on stimulated HUVECs and there are no distinct differences in the surface expression of integrin-type homing receptors LFA-1 (CD11a/CD18; αLβ2) and VLA-4 (CD49d/CD29; α4β1) and chemokine receptor CXCR4 on ML and NL. (PDF 840 kb)

Supplementary Fig. 2

HECA-452–reactive glycoproteins of ML are sensitive to sialidase treatment. (PDF 259 kb)

Supplementary Fig. 3

E-Ig-reactive glycoproteins of ML do not stain in the presence of EDTA or with control human immunoglobulin. (PDF 270 kb)

Supplementary Fig. 4

HECA-452–reactive ∼65 kDa E-selectin ligand does not appear to be related to PSGL-1 or CD44. (PDF 328 kb)

Supplementary Fig. 5

G-CSF treatment significantly enhances the capability of human BM cells to adhere to endothelial E-selectin under physiologic flow conditions. (PDF 330 kb)

Supplementary Fig. 6

HCELL and ∼65 kDa glycoprotein are major E-selectin ligands on ML. (PDF 803 kb)

Supplementary Video 1

This movie shows ML interacting with vascular endothelium within the TNF-α–treated ear. Note the prominent presence of stable rolling interactions. (MOV 2133 kb)

Supplementary Video 2

This movie shows NL interacting with vascular endothelium within the TNF-α–treated ear. Compared to ML (Supplementary Video 1), NL display transient and faster rolling interactions. (MOV 2959 kb)

Supplementary Methods (PDF 139 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dagia, N., Gadhoum, S., Knoblauch, C. et al. G-CSF induces E-selectin ligand expression on human myeloid cells. Nat Med 12, 1185–1190 (2006). https://doi.org/10.1038/nm1470

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1470

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing